Morgan Stanley’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,372
| Closed | -$71.9K | – | 8111 |
|
|
2023
Q4 | $71.9K | Sell |
4,372
-7,616
| -64% | -$120K | ﹤0.01% | 6270 |
|
|
2023
Q3 | $92.7K | Sell |
11,988
-14,192
| -54% | -$76.9K | ﹤0.01% | 5927 |
|
|
2023
Q2 | $136K | Sell |
26,180
-3,850
| -13% | -$19.6K | ﹤0.01% | 5810 |
|
|
2023
Q1 | $161K | Buy |
30,030
+889
| +3% | +$4.83K | ﹤0.01% | 5805 |
|
|
2022
Q4 | $108K | Sell |
29,141
-607
| -2% | -$2.68K | ﹤0.01% | 5944 |
|
|
2022
Q3 | $149K | Sell |
29,748
-6,507
| -18% | -$36.2K | ﹤0.01% | 5882 |
|
|
2022
Q2 | $212K | Buy |
36,255
+5,810
| +19% | +$32.8K | ﹤0.01% | 5867 |
|
|
2022
Q1 | $217K | Sell |
30,445
-9,044
| -23% | -$88.6K | ﹤0.01% | 5876 |
|
|
2021
Q4 | $522K | Buy |
39,489
+24,609
| +165% | +$407K | ﹤0.01% | 5520 |
|
|
2021
Q3 | $342K | Buy |
14,880
+6,337
| +74% | +$189K | ﹤0.01% | 5711 |
|
|
2021
Q2 | $375K | Buy |
8,543
+6,720
| +369% | +$374K | ﹤0.01% | 5699 |
|
|
2021
Q1 | $132K | Sell |
1,823
-55,518
| -97% | -$3.94M | ﹤0.01% | 5875 |
|
|
2020
Q4 | $2.48M | Buy |
57,341
+11,208
| +24% | +$502K | ﹤0.01% | 3966 |
|
|
2020
Q3 | $1.9M | Sell |
46,133
-15,478
| -25% | -$800K | ﹤0.01% | 3698 |
|
|
2020
Q2 | $3.7M | Buy |
61,611
+60,955
| +9,292% | +$5.58M | ﹤0.01% | 2983 |
|
|
2020
Q1 | $49K | Buy |
656
+69
| +12% | +$7.95K | ﹤0.01% | 5472 |
|
|
2019
Q4 | $81K | Sell |
587
-338
| -37% | -$41.1K | ﹤0.01% | 5716 |
|
|
2019
Q3 | $110K | Buy |
925
+910
| +6,067% | +$127K | ﹤0.01% | 5410 |
|
|
2019
Q2 | $2K | Sell |
15
-166
| -92% | -$29.1K | ﹤0.01% | 6485 |
|
|
2019
Q1 | $33K | Sell |
181
-682
| -79% | -$103K | ﹤0.01% | 5842 |
|
|
2018
Q4 | $136K | Buy |
+863
| New | +$129K | ﹤0.01% | 5432 |
|
Morgan Stanley's ORTX Position: Q1 2024 in Review
Morgan Stanley sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 4,372 shares — an estimated $71.9K sold.
Morgan Stanley first reported a position in ORTX in Q4 2018 and held it in 21 quarters. The position peaked at $3.7M in Q2 2020. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.
- Morgan Stanley reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
- Morgan Stanley sold 4,372 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $71.9K.
- Morgan Stanley first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 21 quarters.
- Morgan Stanley's Orchard Therapeutics plc American Depositary Shares position peaked at $3.7M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.